Skip to main content

Table 2 Logistic regression analysis for one-year all-cause mortality

From: Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

Variable

Odds ratio (95% CI)

P value

MR-proADM a

38.64 (12.13 to 123.14)

<0.001

NT-proBNP a

3.46 (2.29 to 5.28)

<0.001

BNP a

3.04 (1.95 to 4.75)

<0.001

Age

1.07 (1.04 to 1.11)

<0.001

eGRF a

0.12 (0.04 to 0.33)

<0.001

Diagnosis of ADHF

2.58 (1.48 to 4.51)

0.001

NYHA class

1.77 (1.23 to 2.57)

0.002

Arterial hypertension

1.28 (0.72 to 2.26)

0.40

Male gender

1.24 (0.73 to 2.10)

0.42

History of coronary artery disease

0.88 (0.49 to 1.58)

0.66

Diabetes mellitus

0.89 (0.45 to 1.78)

0.74

  1. alog-transformed to achieve normal distribution.
  2. ADHF = acute decompensated heart failure; BNP = B-type natriuretic peptide; CI = confidence interval; eGRF = estimated glomerular filtration rate; MR-proADM = midregional pro-adrenomedullin; NT-proBNP = N-terminal pro-B-type natriuretic peptide; NYHA = New York Heart Association.
Back to article page

Critical Care

ISSN: 1364-8535